Nov 16 (Reuters) – Johnson & Johnson said on Monday it had agreed to buy Texas-based biotech Ollin Biosciences, expanding its pipeline of eye disease therapies. Johnson & Johnson will acquire Ollin
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 16 (Reuters) - Megatherm Induction Ltd: * ANNOUNCES TRANSFORMER DIVISION EXPANSION PROJECT INCLUDING 220…
Nov 16 (Reuters) - US President Donald Trump's reported trades this year suggest he held…
LONDON, Nov 16 (Reuters) - British authorities are investigating whether Russell Brand, the comedian found…
AUSTRIA'S FORMER FOREIGN MINISTER KARIN KNEISSL SAYS THAT AUSTRIAN AUTHORITIES HAD INITIATED PROCEEDINGS TO REVOKE…
Apollo Clinic and Apollo Diagnostic’ National Reference Laboratory, have joined forces together to establish a…
Nov 16 (Reuters) - Gaming Corps AB: * FREDRIK GEIJER STEPS DOWN AS CFO OF…